12.13.2012
11:00 am - 1:00 pm GMT
London, UK
Susan Foster will be a panelist in the case study session, "Oxford BioTherapeutics – Menarini deal," at Genesis 2012 which is hosted by One Nucleus and SCRIP Intelligence. Mintz Levin is a proud sponsor of Genesis 2012. Each case study session will focus on one deal in the biopharma space, discussing some of the challenges and solutions relating to matters such as the deal's genesis, challenges in the negotiation or management of the resulting alliance. The discussion will be aided by a panel of biopharma experts who will lead on aspects of the questioning with a view to providing delegates with an insight into the actual or possible solutions implemented and their impact.
Speakers
Panelists
Event Details
Your privacy is important to us. Mintz Levin uses the names, e-mail addresses, and notes you provide only to transmit the information you would like to send to us through this page. We do not sell the information collected through this website to anyone. If you are not a current Mintz Levin client, please do not include any information that you or another party considers confidential on this form. Please also see our Disclaimer & Privacy Statement.